Shahzil Muhammad, Kashif Talha Bin, Jamil Zainab, Khaqan Muhammad Ali, Munir Luqman, Amjad Zunaira, Faisal Muhammad Saad, Chaudhary Ammad Javaid, Ali Hassam, Khan Shahryar, Enofe Ikponmwosa
Department of Internal Medicine Milton S Hershey Medical Center The Pennsylvania State University Hershey Pennsylvania USA.
Department of Internal Medicine King Edward Medical University, Neela Gumbad Lahore Pakistan.
DEN Open. 2025 Apr 30;6(1):e70128. doi: 10.1002/deo2.70128. eCollection 2026 Apr.
Gastrointestinal cancers account for 26% of cancer incidence and 35% of cancer-related deaths globally. Early detection is crucial but often limited by white light endoscopy (WLE), which misses subtle lesions. Texture and color enhancement imaging (TXI), introduced in 2020, enhances texture, brightness, and color, addressing WLE's limitations. This meta-analysis evaluates TXI's effectiveness compared to WLE in gastrointestinal lesion lesion detection.
A systematic review and meta-analysis were conducted per Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Searches of CENTRAL, PubMed, Embase, and Web of Science identified randomized controlled trials and observational studies comparing TXI with WLE. Outcomes included lesion detection rates, color differentiation, and visibility scores. The risk of bias was assessed using the Cochrane ROB 2.0 tool and Newcastle-Ottawa tools, and evidence certainty was evaluated using Grading of Recommendations Assessment, Development, and Evaluation.
Seventeen studies with 16,634 participants were included. TXI significantly improved color differentiation (mean difference: 3.31, 95% confidence interval [CI]: 2.49-4.13), visibility scores (mean difference: 0.50, 95% CI: 0.36-0.64), and lesion detection rates (odds ratio [OR]: 1.84, 95% CI: 1.52-2.22) compared to WLE. Subgroup analyses confirmed TXI's advantages across pharyngeal, esophageal, gastric, and colorectal lesions. TXI also enhanced adenoma detection rates (OR: 1.66, 95% CI: 1.31-2.12) and mean adenoma detection per procedure (mean difference: 0.48, 95% CI: 0.25-0.70).
TXI improves gastriontestinal lesion lesion detection by enhancing visualization and color differentiation, addressing key limitations of WLE. These findings support its integration into routine endoscopy, with further research needed to compare TXI with other modalities and explore its potential in real-time lesion detection.
胃肠道癌症占全球癌症发病率的26%和癌症相关死亡人数的35%。早期检测至关重要,但往往受到白光内镜检查(WLE)的限制,WLE会遗漏细微病变。2020年引入的纹理和颜色增强成像(TXI)可增强纹理、亮度和颜色,弥补了WLE的局限性。本荟萃分析评估了TXI与WLE相比在胃肠道病变检测中的有效性。
按照系统评价和荟萃分析的首选报告项目指南进行了系统评价和荟萃分析。检索CENTRAL、PubMed、Embase和科学网,确定了比较TXI与WLE的随机对照试验和观察性研究。结果包括病变检测率、颜色区分度和可见度评分。使用Cochrane ROB 2.0工具和纽卡斯尔-渥太华工具评估偏倚风险,并使用推荐分级评估、制定和评价对证据确定性进行评估。
纳入了17项研究,共16634名参与者。与WLE相比,TXI显著改善了颜色区分度(平均差值:3.31,95%置信区间[CI]:2.49-4.13)、可见度评分(平均差值:0.50,95%CI:0.36-0.64)和病变检测率(比值比[OR]:1.84,95%CI:1.52-2.22)。亚组分析证实了TXI在咽部、食管、胃和结肠直肠病变中的优势。TXI还提高了腺瘤检测率(OR:1.66,95%CI:1.31-2.12)和每次检查的平均腺瘤检测数(平均差值:0.48,95%CI:0.25-0.70)。
TXI通过增强可视化和颜色区分度改善了胃肠道病变检测,弥补了WLE的关键局限性。这些发现支持将其纳入常规内镜检查,还需要进一步研究以比较TXI与其他模式,并探索其在实时病变检测中的潜力。